Investigator-Initiated Trials (IIT) Forum – Investigator-Initiated Trials (IIT) Forum
Understanding key factors behind investigator-initiated research is highly important for successfully answering important medical and scientific questions, which will uncover solutions to unmet therapeutic needs. These solutions can lead to a successful study that can improve patient care and spark new ideas for further disease-related research that will produce improved medicines for people who need them.
The Investigator-Initiated Trials (IIT) Forum covers all aspects of IITs, including the use of performance measures to optimize trials, considerations for running single vs. multicenter trials, best practices for understanding and fulfilling the expectations of industry and sponsors, structured data, analytics and systems management impact on IITs, and ways to foster compliance and strengthen studies for newer sponsor-investigators.
In addition, this forum speaks to the similarities and differences between research collaborations and IITs, including responsibilities; ownership of the research, royalties and publication rights; and, most crucially, when it’s viable and appropriate to support each type of collaboration.
Join us in Philadelphia and return to work armed with the necessary tools and techniques you need to be successful in managing the pursuit of trials that can lead to new and improved therapies and the discovery of new drug indications.
Top Five Reasons to Attend:
- Discover the value of Investigative research and the tools that are essential for your organization
- Uncover the best way to optimize your IIT through a financial, logistical, and compliance perspective.
- Learn how to strategically manage research collaborations and create an even balance of ownership from concept to conception
- Transform your local programs and develop considerations for trials on a global scale
- Prepare yourself for FDA audits by learning to manage complex regulatory requirements.
Who Should Attend:
This conference is designed for representatives from academic institutions; hospitals; and pharmaceutical, biotechnology and medical device companies whose responsibilities involve:
- Investigator-Initiated Studies
- Investigator-Initiated Research
- Investigator-Initiated Trials
- Investigator-Sponsored Trials
- Research Collaborations
- Medical Affairs/Global Medical Affairs
- Medical/Clinical Operations
- Clinical Project Management
- Clinical Medical Affairs
- Clinical Trial Monitoring
- Research Grants
- Clinical Outcomes and Publications
- Regulatory Affairs